Alana Hippensteele, Associate Editor

Research explores the impact of obesity on prescription opioid use, investigating specifically the link between obesity and long-term prescription use.

The antiviral drug remdesivir was originally developed as a treatment for Ebola in 2014, but upon the surge of COVID-19, its use was investigated in treating COVID-19.

PittCoVacc produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing COVID-19 within 2 weeks.

School closures during the COVID-19 epidemic raises unique challenges regarding the benefits weighed against the costs of resulting health care worker absenteeism.